8-K - Kymera Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

. Results of Operations and Financial Condition On February 26, 2026, Kymera Therapeutics, Inc. announced its financial results for the quarter ended December 3

Financial Results

9.01

. Exhibits (d) Exhibits Exhibit No. Description 99.1 Press release issued by Kymera Therapeutics, Inc. on February 26, 2026, furnished herewith. 104 Cover Page

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1